Inaugural Global Innovations in Patient-Centered Kidney Care presented by the American Association of Kidney Patients & George Washington University
May 21 – 23, 2019
George Washington University Campus, Washington, D.C.
The Inaugural Global Innovations in Patient-Centered Kidney Care is a two-day inaugural event designed to engage the top international experts in the field of kidney care including healthcare professionals; academics; government leaders and regulators; industry experts, entrepreneurs; and patient advocates.
Registration includes the following*:
• April 10th: Early check-in and evening Welcome Reception
• April 11th: Full day of panel sessions (lunch provided)
• April 12th: Full day of panel sessions (lunch provided)
*Please note, breakfasts and dinners are on your own. We encourage you to network and enjoy D.C.!
• Kidney Patients: $0
• Medical Students: $0
• Fellows: $125
• Advanced Practice Providers (e.g. NP, PA, etc.): $125
• Academics (PhD): $250
• Practicing Nephrologist: $250
• Industry Representative: $350
Agenda may be subject to change
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of The George Washington University School of Medicine and Health Sciences and The American Association of Kidney Patients. The George Washington University School of Medicine and Health Sciences is accredited by the ACCME to provide continuing medical education for physicians.
*Travel and housing information will be sent via email to registered attendees.
Travel and lodging expenses must be covered by the attendee.
For more information about this program, or for sponsorship opportunities, please contact:
Erin Kahle, Director of Stakeholder Operations, email@example.com or (800) 400-2393.
More Announcements Coming!
Roberto Flavio Silva, MD, PhD, FACP, FASN, Pontifícia Universidade Católica do Paraná (Brazil); Dominic Raj, MD, DM, FASN, George Washington University School of Medicine & Health Sciences; Gerald B. Appel, MD, PhD, New York Presbyterian; Jeffrey Akman, MD, George Washington University School of Medicine & Health Sciences; George Bakris, MD, Comprehensive Hypertension Center; Alan Wasserman, MD, MACP, GW Medical Faculty Associates; Richard Knight, American Association of Kidney Patients; Juliana Blum, PhD, Humacyte; Bruce Culleton, MD, CVS Health; Harold I. Feldman, MD, MSCE, University of Pennsylvania; Courtney Firak, MPH, Continuum Clinical; Barry I. Freedman, MD, FACP, Wake Forest School of Medicine; Victor Gura, MD, Cedars-Sinai Medical Center; Tod Ibrahim, American Society of Nephrology; Eric Litjens, PhD, Hansa Medical (Sweden); Joe Muldoon, FAST BioMedical; Diana Clynes, American Association of Kidney Patients; Carolyn Neuland, PhD, U.S. Food and Drug Administration; Jim Sloand , MD, FACP, FASN, AstraZeneca (United Kingdom); Erin Kahle, American Association of Kidney; Barry Smith, PhD, MD, The Rogosin Institute; Robert Star, MD, National Institute of Health; Aliza Thompson, MD, MS, U.S. Food and Drug Administration; Anton Sidawy, MD, MPH, FACS, GW Medical Faculty Associates; Paul T. Conway, American Association of Kidney Patients; Michael Walsh, MD, PhD, McMaster University (Canada)
About Global Summit Partners:
American Association of Kidney Patients (AAKP) is celebrating its 50th Anniversary as the oldest and largest fully independent kidney patient organization in the United States. AAKP patients led the effort in the U.S. Congress and with senior White House officials to establish the End Stage Renal Disease Program in 1973, which has saved over a million lives through dialysis coverage. With a patient-majority led Board of Directors, AAKP works globally with patients and drug and device development companies on treatment design, clinical trials and patient education and mobilization. AAKP fights for early detection; increased kidney transplantation and pre-emptive transplantation; full patient choice either at-home or in-center dialysis; protection of the patient/physician relationship; promotion of research and innovation; and the elimination of barriers for patient access to available treatment options.
George Washington School of Medicine Founded in 1824, the GW School of Medicine and Health Sciences (SMHS) is the 11th oldest medical school in the country and the first in the nation’s capital. Since its establishment, the school has been at the forefront of medical education, and has grown to include highly-ranked programs in the health and biomedical sciences. With dozens of top-tier residency programs, SMHS is a competitive and esteemed destination for medical school graduates across the country. Today, students and residents are exposed to some of the most innovative educational techniques, taught by world-renowned faculty members, in state-of-the-art facilities.